Table 3.
Total cohort | Sex |
Puberty |
|||
---|---|---|---|---|---|
female | male | prepubertal | pubertal | ||
Age (years)a | −0.29** | −0.31* | −0.41** | −0.15 | −0.07 |
BMI SDSa | 0.55*** | 0.49*** | 0.55*** | 0.52*** | 0.51*** |
Fasting insulin | −0.14 | −0.22 | −0.15 | 0.02 | 0.09 |
HOMA-IR | −0.14 | −0.21 | −0.14 | −0.03 | 0.12 |
AUC insulin | 0.07 | −0.06 | 0.13 | 0.13 | 0.22 |
Oestradiol SDSa | 0.14 | 0.13 | 0.13 | − | 0.10 |
Testosterone SDS | 0.24 | 0.44* | −0.06 | − | 0.18 |
DHEAS SDS | 0.29** | 0.18 | 0.33* | 0.32* | 0.28* |
SHBG SDS | −0.17 | −0.10 | −0.22 | −0.24 | −0.31* |
Correlations are expressed as Spearman ρ (p value) unless otherwise stated. Correlations for oestradiol SDS and testosterone SDS are calculated on the age group of ≥9 years. SDS, standard deviation score; BA, bone age; BMI, body mass index; HOMA-IR, homeostatic model assessment of insulin resistance; AUC, area under the curve; DHEAS, dehydroepiandrosterone sulphate; SHBG, sex hormone-binding globulin.
Pearson correlation (p value).
p < 0.05
p < 0.01
p < 0.001.